kidney semaglutide AHA 2024: continues to impress in diabetic disease Semaglutide: A New Era in
Description
(3) Retatrutide Retatrutide is an investigational medication currently undergoing clinical trials for obesity treatment
This suggests that while AFib can occur, it is not a common side effect of semaglutide
When considering the research studies conducted, patients can lose anywhere from 15% to 25% of their body weight on these medications
You must be aware of the potential side effects when taking Ozempic and consult with your healthcare provider if you experience any new symptoms
